Roche’s shocking Tecentriq fail raises red flag for bladder cancer rivals esagonowsky Wed, 05/10/2017 – 11:36 More: Roche’s shocking Tecentriq fail raises red flag for bladder cancer rivals Source: fierce
read moreJudge tosses lawsuit against Pfizer, BMS over Eliquis bleeding risks esagonowsky Wed, 05/10/2017 – 11:19 More: Judge tosses lawsuit against Pfizer, BMS over Eliquis bleeding risks Source: fierce
read morePhRMA expels 22 members with new R&D rules as it works to burnish its image epalmer Wed, 05/10/2017 – 10:29 More: PhRMA expels 22 members with new R&D rules as it works to burnish its image Source: fierce
read moreDespite pricing outcry, branded pharma kept double-digit hikes coming in 2016: report esagonowsky Wed, 05/10/2017 – 09:53 More: Despite pricing outcry, branded pharma kept double-digit hikes coming in 2016: report Source: fierce
read moreEU regulators have issued a green light for the first immunotherapy for high-risk neuroblastoma, offering thousands of children affected by the rare and devastating form of cancer a new treatment option. More: EU approves first immunotherapy for neuroblastoma Source: News
read moreMerck and Pfizer have announced a second accelerated approval in the US for Bavencio in less than two months, in this instance for certain patients with metastatic urothelial carcinoma. More: Second US approval for Merck, Pfizer’s Bavencio Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals